Background and General



We are a producer and distributor of premium specialty alloys, including
titanium alloys, powder metals, stainless steels, alloy steels and tool steels.
We are a recognized leader in high-performance specialty alloy-based materials
and process solutions for critical applications in the aerospace, defense,
medical, transportation, energy, industrial and consumer markets. We have
evolved to become a pioneer in premium specialty alloys, including titanium,
nickel, and cobalt, as well as alloys specifically engineered for additive
manufacturing ("AM") processes and soft magnetics applications. We have expanded
our AM capabilities to provide a complete "end-to-end" solution to accelerate
materials innovation and streamline parts production. We primarily process basic
raw materials such as nickel, cobalt, titanium, manganese, chromium, molybdenum,
iron scrap and other metal alloying elements through various melting, hot
forming and cold working facilities to produce finished products in the form of
billet, bar, rod, wire and narrow strip in many sizes and finishes. We also
produce certain metal powders and parts. Our sales are distributed directly from
our production plants and distribution network as well as through independent
distributors. Unlike many other specialty steel producers, we operate our own
worldwide network of service and distribution centers. These service centers,
located in the United States, Canada, Mexico, Europe and Asia allow us to work
more closely with customers and to offer various just-in-time stocking programs.

As part of our overall business strategy, we have sought out and considered
opportunities related to strategic acquisitions and joint collaborations as well
as possible business unit dispositions aimed at broadening our offering to the
marketplace. We have participated with other companies to explore potential
terms and structures of such opportunities and expect that we will continue to
evaluate these opportunities.

Our discussions below in this Item 2 are based upon the more detailed
discussions about our business, operations and financial condition included in
Item 7 of our 2022 Form 10-K. Our discussions here focus on our results during
or as of the three-month period ended September 30, 2022 and the comparable
period of fiscal year 2022, and to the extent applicable, on material changes
from information discussed in the 2022 Form 10-K and other important intervening
developments or information that we have reported on Form 8-K. These discussions
should be read in conjunction with the 2022 Form 10-K for detailed background
information and with any such intervening Form 8-K.

                                       27
--------------------------------------------------------------------------------
  Table of Contents
Impact of Raw Material Prices and Product Mix

We value most of our inventory utilizing the last-in, first-out ("LIFO")
inventory costing method. Under the LIFO inventory costing method, changes in
the cost of raw materials and production activities are recognized in cost of
sales in the current period even though these materials may potentially have
been acquired at significantly different values due to the length of time from
the acquisition of the raw materials to the sale of the processed finished goods
to the customers. In a period of rising raw material costs, the LIFO inventory
valuation normally results in higher cost of sales. Conversely, in a period of
decreasing raw material costs, the LIFO inventory valuation normally results in
lower cost of sales.

The volatility of the costs of raw materials has impacted our operations over
the past several years. We, and others in our industry, generally have been able
to pass cost increases on major raw materials through to our customers using
surcharges that are structured to recover increases in raw material costs.
Generally, the formula used to calculate a surcharge is based on published
prices of the respective raw materials for the previous month which correlates
to the prices we pay for our raw material purchases. However, a portion of our
surcharges to customers may be calculated using a different surcharge formula or
may be based on the raw material prices at the time of order, which creates a
lag between surcharge revenue and corresponding raw material costs recognized in
cost of sales. The surcharge mechanism protects our net income on such sales
except for the lag effect discussed above. However, surcharges have had a
dilutive effect on our gross margin and operating margin percentages as
described later in this report.

Approximately 40 percent of our net sales are sales to customers under firm
price sales arrangements. Firm price sales arrangements involve a risk of profit
margin fluctuations, particularly when raw material prices are volatile. In
order to reduce the risk of fluctuating profit margins on these sales, we enter
into commodity forward contracts to purchase certain critical raw materials
necessary to produce the related products sold. Firm price sales arrangements
generally include certain annual purchasing commitments and consumption
schedules agreed to by the customers at selling prices based on raw material
prices at the time the arrangements are established. If a customer fails to meet
the volume commitments (or the consumption schedule deviates from the
agreed-upon terms of the firm price sales arrangements), we may need to absorb
the gains or losses associated with the commodity forward contracts on a
temporary basis. Gains or losses associated with commodity forward contracts are
reclassified to earnings/loss when earnings are impacted by the hedged
transaction. Because we value most of our inventory under the LIFO costing
methodology, changes in the cost of raw materials and production activities are
recognized in cost of sales in the current period attempting to match the most
recently incurred costs with revenues. Gains or losses on the commodity forward
contracts are reclassified from other comprehensive (loss) income together with
the actual purchase price of the underlying commodities when the underlying
commodities are purchased and recorded in inventory. To the extent that the
total purchase price of the commodities, inclusive of the gains or losses on the
commodity forward contracts, are higher or lower relative to the beginning of
year costs, our cost of goods sold reflects such amounts. Accordingly, the gains
and/or losses associated with commodity forward contracts may not impact the
same period that the firm price sales arrangements revenue is recognized, and
comparisons of gross profit from period to period may be impacted. These firm
price sales arrangements are expected to continue as we look to strengthen our
long-term customer relationships by expanding, renewing and in certain cases
extending to a longer-term, our customer long-term arrangements.

We produce hundreds of grades of materials with a wide range of pricing and
profit levels depending on the grade. In addition, our product mix within a
period is subject to the fluctuating order patterns of our customers as well as
decisions we may make on participation in certain products based on available
capacity, including the impacts of capacity commitments we may have under
existing customer agreements. While we expect to see positive contribution from
a more favorable product mix in our margin performance over time, the impact by
period may fluctuate and period-to-period comparisons may vary.

                                       28
--------------------------------------------------------------------------------
  Table of Contents
Net Pension Benefit

Net pension benefit, as we define it below, includes the net periodic benefit costs related to both our pension and other postretirement plans. The net periodic benefit costs are determined annually based on beginning of year balances and are recorded ratably throughout the fiscal year, unless a significant remeasurement event occurs. We currently expect the total net pension expense for fiscal year 2023 will be $19.6 million as compared with total net pension income of $7.3 million in fiscal year 2022.

The following is the net pension expense (income) for the three months ended September 30, 2022 and September 30, 2021:



                                        Three Months Ended
                                          September 30,
($ in millions)                          2022             2021
Pension plans                     $     5.2             $ (1.0)
Other postretirement plans             (0.2)              (0.8)
Net pension expense (income)      $     5.0             $ (1.8)



Net pension expense (income) is recorded in accounts that are included in cost
of sales and selling, general and administrative expenses based on the function
of the associated employees and in other expense (income), net. The following is
a summary of the classification of net pension expense (income) for the three
months ended September 30, 2022 and 2021:


                                                                              Three Months Ended
                                                                                September 30,
($ in millions)                                                            2022                2021

Service cost included in Cost of sales                                 $    

2.2 $ 2.4

Service cost included in Selling, general and administrative expenses

                                                                      0.3                0.3

Pension earnings, interest and deferrals included in Other expense (income), net

                                                         2.5               (4.5)

Net pension expense (income)                                           $    

5.0 $ (1.8)





As of September 30, 2022 and June 30, 2022, service cost amounts related to the
net pension expense (income) capitalized in gross inventory were $2.6 million
and $1.7 million, respectively.

Operating Performance Overview



During the quarter ended September 30, 2022, demand in each of our end-use
markets remained strong, with our backlog up 10 percent sequentially and 155
percent year-over-year. The growth was led by increasing sales across each of
the Aerospace sub-markets with lead times extending for our materials. The SAO
segment finished the quarter ended September 30, 2022, at the upper end of our
expected range, driven by the aerospace growth and continued improvement in our
operations. The PEP segment came in just below expectations due to delayed
shipments caused by Hurricane Ian at our Dynamet facility in Florida. We remain
confident as we continue to see strength across all of our end-use markets with
order entry activity driving backlog growth, and with continued improvement in
our operations.

Results of Operations - Three Months Ended September 30, 2022 vs. Three Months Ended September 30, 2021



For the three months ended September 30, 2022, we reported net loss of $6.9
million, or $0.14 loss per diluted share. This compares with net loss for the
same period a year earlier of $14.8 million, or $0.31 loss per diluted share.
There were no reported special items for the quarter ended September 30, 2022.
COVID-19 related costs negatively impacted operating results by $1.6 million in
the three months ended September 30, 2021. Excluding these costs, adjusted loss
per diluted share was $0.28 for the quarter ended September 30, 2021. The
results for the three months ended September 30, 2022 reflect improving demand
patterns, higher prices and improving mix with 35 percent increased sales
compared to the prior year quarter.

                                       29
--------------------------------------------------------------------------------
  Table of Contents
Net Sales

Net sales for the three months ended September 30, 2022 were $522.9 million,
which was a 35 percent increase over the same period a year ago. Excluding
surcharge revenue, sales increased 20 percent on a 3 percent increase in
shipment volume from the same period a year ago. The results reflect higher
demand in all end-use markets except Transportation during the three months
ended September 30, 2022 compared to the three months ended September 30, 2021.
Net sales in the Aerospace and Defense end-use market increased 57 percent
compared to the same period a year ago.

Geographically, sales in the United States increased 29 percent from the same
period a year ago to $319.6 million. The increase is driven by higher demand in
all end-use markets except Transportation. Sales outside the United States
increased 44 percent from the same period a year ago to $203.3 million for the
three months ended September 30, 2022. The increase is driven primarily by
higher demand in the Aerospace and Defense end-use market in the European and
South America regions. A portion of our sales outside the United States are
denominated in foreign currencies. The fluctuations in foreign currency exchange
rates resulted in a $2.8 million decrease in sales during the three months ended
September 30, 2022 compared to the three months ended September 30, 2021. Net
sales outside the United States represented 39 percent and 36 percent of total
net sales for the three months ended September 30, 2022 and 2021, respectively.

Sales by End-Use Markets



We sell to customers across diversified end-use markets. The following table
includes comparative information for our net sales, which includes surcharge
revenue by principal end-use markets. We believe this is helpful supplemental
information in analyzing the performance of the business from period to period:



                                                               Three Months Ended                       $
                                                                  September 30,                     Increase                    %
($ in millions)                                              2022                 2021             (Decrease)          Increase (Decrease)

Aerospace and Defense                                  $    261.6             $   166.9          $       94.7                         57  %
Medical                                                      59.2                  43.1                  16.1                         37  %
Transportation                                               36.9                  41.6                  (4.7)                       (11) %
Energy                                                       27.9                  22.2                   5.7                         26  %
Industrial and Consumer                                     105.0                  86.6                  18.4                         21  %
Distribution                                                 32.3                  27.2                   5.1                         19  %
Total net sales                                        $    522.9             $   387.6          $      135.3                         35  %


The following table includes comparative information for our net sales by the same principal end-use markets, but excluding surcharge revenue:





                                                          Three Months Ended                       $
                                                             September 30,                      Increase                    %
($ in millions)                                         2022                 2021              (Decrease)          Increase (Decrease)

Aerospace and Defense                             $    183.5             $   134.9          $        48.6                         36  %
Medical                                                 49.8                  37.1                   12.7                         34  %
Transportation                                          23.7                  31.4                   (7.7)                       (25) %
Energy                                                  18.3                  16.2                    2.1                         13  %
Industrial and Consumer                                 68.4                  66.3                    2.1                          3  %
Distribution                                            32.0                  27.0                    5.0                         19  %
Total net sales excluding surcharge revenue       $    375.7             $   312.9          $        62.8                         20  %



                                       30

--------------------------------------------------------------------------------
  Table of Contents
Sales to the Aerospace and Defense end-use market increased 57 percent from the
first quarter a year ago to $261.6 million. Excluding surcharge revenue, sales
increased 36 percent from the first quarter a year ago on a 24 percent increase
in shipment volume. The results for the three months ended September 30, 2022
reflect increases in all sub-markets driven by ramping activity levels across
the aerospace supply change due to higher aircraft build rates to meet
increasing passenger travel.

Medical end-use market sales increased 37 percent from the first quarter a year
ago to $59.2 million. Excluding surcharge revenue, sales increased 34 percent on
20 percent higher shipment volume from the first quarter a year ago. The current
first quarter results reflect stronger demand as a result of the medical supply
chain replenishing inventory levels with steady increases in elective medical
procedures.

Transportation end-use market sales decreased 11 percent from the first quarter
a year ago to $36.9 million. Excluding surcharge revenue, sales decreased 25
percent on 42 percent lower shipment volume from the first quarter a year ago.
The results reflect reduced heavy-duty build rates from ongoing supply shortages
and lower demand for light, medium and heavy duty vehicles internationally.

Sales to the Energy end-use market of $27.9 million in the current quarter reflect a 26 percent increase from the first quarter a year ago. Excluding surcharge revenue, sales increased 13 percent from a year ago. The results reflect increasing global rig counts benefiting the oil and gas sub-market partially offset by lower sales for power generation materials compared to the prior year period.



Industrial and Consumer end-use market sales of $105.0 million increased $18.4
million compared to the first quarter a year ago. Excluding surcharge revenue,
sales increased 3 percent on 2 percent lower shipment volume. The results
reflect higher demand for semiconductor materials and increased sales in the
electronic sub-market.

Gross Profit

Our gross profit in the first quarter increased $29.6 million to $54.8 million,
or 10.5 percent of net sales as compared with $25.2 million, or 6.5 percent of
net sales in the same quarter a year ago. Excluding the impact of surcharge
revenue, our adjusted gross margin in the first quarter was 14.6 percent as
compared to 8.1 percent in the same period a year ago. The increased gross
profit for the three months ended September 30, 2022 reflects improving demand
patterns with 35 percent increased sales and a stronger product mix, higher
prices and improved operational efficiencies.

While the surcharge generally protects the absolute gross profit dollars, it
does have a dilutive effect on gross margin as a percent of sales. The following
represents a summary of the dilutive impact of the surcharge on gross margin for
the comparative three-month periods. See the section "Non-GAAP Financial
Measures" below for further discussion of these financial measures.

                                                      Three Months Ended
                                                         September 30,
($ in millions)                                        2022               2021
Net sales                                     $                522.9    $   387.6
Less: surcharge revenue                                        147.2         74.7
Net sales excluding surcharge revenue         $                375.7    $   312.9

Gross profit                                  $                 54.8    $    25.2

Gross margin                                                 10.5  %       6.5  %

Gross margin excluding surcharge revenue                     14.6  %       8.1  %



                                       31

--------------------------------------------------------------------------------
  Table of Contents
Selling, General and Administrative Expenses

Selling, general and administrative expenses of $46.5 million were 8.9 percent
of net sales (12.4 percent of net sales excluding surcharge) as compared with
$44.3 million and 11.4 percent of net sales (14.2 percent of net sales excluding
surcharge) in the same quarter a year ago. The selling, general and
administrative expenses for the three months ended September 30, 2022 reflect
higher salary and benefit costs compared to the same period a year ago.
.
Operating Income (Loss)

Our operating income in the recent first quarter was $8.3 million, or 1.6
percent of net sales, as compared with operating loss of $19.1 million or
negative 4.9 percent of net sales in the same quarter a year ago. Excluding
surcharge revenue, adjusted operating margin was 2.2 percent for the current
quarter as compared with negative 5.6 percent a year ago excluding special
items. The operating results for the three months ended September 30, 2022
reflect higher sales compared to the prior year quarter and improved operational
efficiencies. The three months ended September 30, 2021 reflected the ongoing
impact from COVID-19 with lower demand and operational challenges with labor
shortages and supply chain interruptions.

The following presents our operating income (loss) and operating margin, in each
case excluding the impact of surcharge revenue on net sales and special items.
We present and discuss these financial measures because management believes
removing these items provides a more consistent and meaningful basis for
comparing ongoing results of operations from period to period. See the section
"Non-GAAP Financial Measures" below for further discussion of these financial
measures.

                                                                                Three Months Ended
                                                                                  September 30,
($ in millions)                                                              2022                 2021
Net sales                                                              $          522.9       $       387.6
Less: surcharge revenue                                                           147.2                74.7
Net sales excluding surcharge revenue                                  $          375.7       $       312.9

Operating income (loss)                                                $            8.3       $      (19.1)
Special item:

 COVID-19 costs                                                                       -                 1.6

Adjusted operating income (loss)                                       $            8.3       $      (17.5)

Operating margin                                                                 1.6  %             (4.9) %

Adjusted operating margin excluding surcharge revenue and
special item                                                                     2.2  %             (5.6) %



Interest Expense, Net

Interest expense, net for the three months ended September 30, 2022 was $12.6
million compared with $10.2 million in the same period a year ago. Capitalized
interest reduced interest expense by $0.3 million for the three months ended
September 30, 2022 and $0.1 million for the three months ended September 30,
2021. The higher interest expense is largely due to higher interest costs on
debt that was refinanced.

Other Expense (Income), Net

Other expense, net for the three months ended September 30, 2022 was $3.5
million as compared with $4.1 million of other income, net for the three months
ended September 30, 2021. The current quarter reflects $2.5 million of expense
from pension earnings, interest and deferrals compared to $4.5 million of
pension income in the prior year driven by favorable returns on plan assets.

                                       32
--------------------------------------------------------------------------------
  Table of Contents
Income Taxes

Income tax benefit was $0.9 million, or 11.5 percent of pre-tax loss for the
three months ended September 30, 2022, as compared with $10.4 million, or 41.3
percent of pre-tax loss in the same quarter a year ago. Income tax benefit for
the three months ended September 30, 2022 includes the unfavorable impact of
losses in certain foreign jurisdictions for which no tax benefit can be
recognized. Also included is a discrete tax charge of $0.6 million for the
impact of a state tax legislative change and a discrete tax benefit of
$0.3 million attributable to employee share-based compensation. Income tax
benefit for the three months ended September 30, 2021 included the unfavorable
impacts of losses in certain foreign jurisdictions for which no tax benefit can
be recognized.

The Inflation Reduction Act of 2022 (the "IRA") was enacted on August 16, 2022.
The IRA includes climate and energy provisions, extends the Affordable Care Act
subsidies, increases Internal Revenue Enforcement funding and allows Medicare to
negotiate prescription drug prices. The IRA creates a 15 percent corporate
alternative minimum tax on profits of corporations whose average annual adjusted
financial statement income for any consecutive three-tax-year period preceding
the tax year exceeds $1.0 billion and is effective for tax years beginning after
December 31, 2022. The IRA also creates an excise tax of 1 percent on stock
repurchases by publicly traded U.S. corporations, effective for repurchases
after December 31, 2022. The provisions of the IRA are not expected to have a
significant impact on our financial position, results of operations or cash
flows.

Business Segment Results

We have two reportable business segments: SAO and PEP.



The following table includes comparative information for volumes by business
segment:

                                                                           Three Months Ended
                                                                             September 30,                                                               %
(Pounds sold, in thousands)                                         2022                       2021                Increase (Decrease)          Increase (Decrease)
Specialty Alloys Operations                                          44,562                     43,008                     1,554                                4  %
Performance Engineered Products *                                     2,326                      2,372                       (46)                              (2) %
Intersegment                                                         (1,998)                    (1,852)                     (146)                              (8) %
Consolidated pounds sold                                             44,890

                    43,528                     1,362                                3  %


* Pounds sold data for PEP segment includes Dynamet and Additive businesses only.



The following table includes comparative information for net sales by business
segment:
                                          Three Months Ended
                                             September 30,                $             %
($ in millions)                            2022            2021        Increase      Increase
Specialty Alloys Operations          $    447.3          $ 331.9      $  115.4           35  %
Performance Engineered Products            93.2             74.6          18.6           25  %
Intersegment                              (17.6)           (18.9)          1.3            7  %
Total net sales                      $    522.9          $ 387.6      $  135.3           35  %


The following table includes comparative information for our net sales by business segment, but excluding surcharge revenue:


                                                          Three Months Ended
                                                             September 30,                        $                     %
($ in millions)                                         2022                 2021             Increase               Increase
Specialty Alloys Operations                       $    305.7             $   258.2          $     47.5                       18  %
Performance Engineered Products                         87.7                  73.6                14.1                       19  %
Intersegment                                           (17.7)                (18.9)                1.2                        6  %
Total net sales excluding surcharge revenue       $    375.7             $   312.9          $     62.8                       20  %



                                       33

--------------------------------------------------------------------------------
  Table of Contents
Specialty Alloys Operations Segment

Net sales for the quarter ended September 30, 2022 for the SAO segment increased
35 percent to $447.3 million, as compared with $331.9 million in the same
quarter a year ago. Excluding surcharge revenue, net sales for the current
quarter increased 18 percent on 4 percent higher shipment volume from a year
ago. The higher sales in the SAO segment reflect increases in all end-use
markets except Transportation driven by improving demand and price increases
compared to the prior year same quarter.

Operating income for the SAO segment was $19.9 million or 4.4 percent of net
sales (6.5 percent of net sales excluding surcharge revenue) in the recent first
quarter, as compared with operating loss of $5.9 million or negative 1.8 percent
of net sales (negative 2.3 percent of net sales excluding surcharge revenue) in
the same quarter a year ago. The operating income reflects higher volume in all
end-use markets except Transportation and Industrial and Consumer, stronger
product mix and improved operational efficiencies in the quarter ended
September 30, 2022. The results for the quarter ended September 30, 2021
continued to be impacted by COVID-19 including labor shortages and supply chain
disruptions.

Performance Engineered Products Segment



Net sales for the quarter ended September 30, 2022 for the PEP segment increased
25 percent to $93.2 million, as compared with $74.6 million in the same quarter
a year ago. Excluding surcharge revenue, net sales for the current quarter of
$87.7 million increased from $73.6 million a year ago. The results reflect
improving demand in all end-use markets except Industrial and Consumer compared
to the prior year period. In particular, the Medical end-use market increased 45
percent with steady increases in elective surgical procedures compared to the
same period last year.

Operating income for the PEP segment was $6.3 million or 6.8 percent of net
sales (7.2 percent of net sales excluding surcharge revenue) in the current
first quarter, compared with operating income of $0.6 million or 0.8 percent of
net sales in the same quarter a year ago. The improved results for the quarter
ended September 30, 2022 reflect stronger demand conditions partially offset by
delayed shipments caused by Hurricane Ian at our Dynamet facility in Florida.

Liquidity and Financial Resources



During the three months ended September 30, 2022, we used cash for operating
activities of $78.0 million compared to cash used for operating activities of
$47.0 million in the same period a year ago. Our free cash flow, which we define
under "Non-GAAP Financial Measures" below, was negative $101.3 million as
compared to negative $71.2 million for the same period a year ago. The decrease
in cash provided from operating activities and free cash flow for the three
months ended September 30, 2022 compared to the same period a year ago resulted
from higher inventory to meet growing demand partially offset by improved
earnings. Cash used to build inventory was $121.2 million in the current period
ended September 30, 2022 compared to $66.5 million in the same period a year
ago. The increase in inventory during the current fiscal year is in response to
growing demand. During the three months ended September 30, 2022, cash used for
accounts receivable was $12.1 million compared to $3.8 million in the same
period a year ago.

Capital expenditures for property, plant, equipment and software were $13.5 million for the three months ended September 30, 2022 as compared to $14.4 million for the same period a year ago. In fiscal year 2023, we expect capital expenditures to be approximately $100 million.



Dividends during the three months ended September 30, 2022 and 2021 were $9.8
million and $9.8 million, respectively, and were paid at the same quarterly rate
of $0.20 per share of common stock in both periods.

We have demonstrated the ability to generate cash to meet our needs through cash
flows from operations, management of working capital and the ability to access
capital markets to supplement internally generated funds. We target minimum
liquidity of $150 million, consisting of cash and cash equivalents added to
available borrowing capacity under our Credit Facility.

                                       34
--------------------------------------------------------------------------------
  Table of Contents
On March 26, 2021, we entered into our $300.0 million secured revolving Credit
Facility. The Credit Facility amended and restated our previous revolving credit
facility, dated March 31, 2017, which had been set to expire in March 2022. The
Credit Facility extends the maturity to March 31, 2024, subject to a springing
maturity of November 30, 2022. If, by November 30, 2022, our $300.0 million
4.45% Senior Notes due in March 2023 were not redeemed, repurchased or
refinanced with indebtedness having a maturity date of October 1, 2024 or later,
all indebtedness under the Credit Facility will be due. The springing maturity
clause has been satisfied with the issuance of the 2030 Notes and subsequent
payment in full of the 4.45% Senior Notes, as discussed in Note 8 Debt. The
Credit Facility contains a revolving credit commitment amount of $300.0 million,
subject to our right, from time to time, to request an increase of the
commitment to $500.0 million in the aggregate; and provides for the issuance of
letters of credit subject to a $40.0 million sub-limit. We have the right to
voluntarily prepay and re-borrow loans, to terminate or reduce the commitments
under the Credit Facility, and, subject to certain lender approvals, to join
subsidiaries as subsidiary borrowers.

On February 14, 2022, we entered into the Amendment to the Credit Facility. The
Amendment revised the interest coverage ratio covenant under the Credit Facility
so that the first test date was June 30, 2022, and required a minimum interest
coverage ratio of 2.00 to 1.00 at June 30, 2022 (calculated for the two fiscal
quarters then ended), 3.00 to 1.00 at September 30, 2022 (calculated for the
three fiscal quarters then ended) and 3.50 to 1.00 at December 31, 2022 and
thereafter (calculated for the four fiscal quarters then ended). The Amendment
revised the restricted period under the Credit Facility, during which we were
prohibited from incurring any secured debt other than purchase money financing
for new equipment and were subject to additional restrictions on its ability to
make dividends or distributions or to make certain investments. This expired on
September 30, 2022.

As of September 30, 2022, we had $1.8 million of issued letters of credit and no
short-term borrowings under the Credit Facility. The balance of the Credit
Facility, $298.2 million, remains available to us. As of September 30, 2022, the
borrowing rate for the Credit Facility was 5.12%.

We believe that our total liquidity of $350.8 million as of September 30, 2022,
which includes total cash and cash equivalents of $52.6 million and available
borrowing capacity of $298.2 million under our credit facility, will be
sufficient to fund our cash needs over the foreseeable future.

During the three months ended September 30, 2022, we made no pension
contributions to our qualified defined benefit pension plans. We currently do
not expect to contribute to our qualified defined benefit pension plans during
the remainder of fiscal year 2023.

As of September 30, 2022, we had cash and cash equivalents of approximately
$17.9 million held at various foreign subsidiaries. Our global deployment
considers, among other things, geographic location of our subsidiaries' cash
balances, the locations of our anticipated liquidity needs, and the cost to
access international cash balances, as necessary. During the three months ended
September 30, 2022, we repatriated no cash from foreign jurisdictions. From time
to time, we may make short-term intercompany borrowings against our cash held
outside the United States in order to reduce or eliminate any required borrowing
under our Credit Agreement.

                                       35
--------------------------------------------------------------------------------
  Table of Contents
We are subject to certain financial and restrictive covenants under the Credit
Facility, which, among other things, require the maintenance of a minimum
interest coverage ratio. The interest coverage ratio is defined in the Credit
Facility as, for any period, the ratio of consolidated earnings before interest,
taxes, depreciation and amortization and non-cash net pension expense ("EBITDA")
to consolidated interest expense for such period. The interest coverage covenant
was waived until the quarter ended June 30, 2022 at which time it was required
to be 2.00 to 1.00, for the quarter ended September 30, 2022 it is 3.00 to 1.00
and then 3.50 to 1.00 thereafter. The Credit Facility also requires us to
maintain a debt to capital ratio of less than 55 percent. The debt to capital
ratio is defined in the Credit Facility as the ratio of consolidated
indebtedness, as defined therein, to consolidated capitalization, as defined
therein. In addition, we are subject to an asset coverage ratio minimum of 1.10
to 1.00. The asset coverage ratio is defined in the Credit Facility as eligible
receivables and inventory, as defined therein, to outstanding loans and
obligations, as defined therein. As of September 30, 2022, we were in compliance
with all of the covenants of the Credit Facility.

The following table shows our actual ratio performance with respect to the financial covenants as of September 30, 2022:




Covenant                                    Covenant Requirement       Actual Ratio

Consolidated debt to capital                   55% (maximum)                35%

Consolidated interest coverage ratio 3.00 to 1.00 (minimum) 3.69 to 1.00 Asset coverage ratio

                       1.10 to 1.00 (minimum)      233.7 to 1.00



To the extent that we do not comply with the current or modified covenants under the Credit Facility, this could reduce our liquidity and flexibility due to potential restrictions on borrowings available to us unless we are able to obtain waivers or modifications of the covenants.

Non-GAAP Financial Measures

The following provides additional information regarding certain non-GAAP financial measures that we use in this report. Our definitions and calculations of these items may not necessarily be the same as those used by other companies.

Net Sales and Gross Margin Excluding Surcharge Revenue and Special Items



This report includes discussions of net sales as adjusted to exclude the impact
of raw material surcharge and special items and the resulting impact on gross
margins, which represent financial measures that have not been determined in
accordance with accounting principles generally accepted in the United States of
America ("U.S. GAAP"). We present and discuss these financial measures because
management believes removing the impact of raw material surcharge from net sales
provides a more consistent basis for comparing results of operations from period
to period for the reasons discussed earlier in this report. Management uses its
results excluding these amounts to evaluate its operating performance and to
discuss its business with investment institutions, our board of directors and
others. See our earlier discussion of "Gross Profit" for a reconciliation of net
sales and gross margin, excluding surcharge revenue, to net sales as determined
in accordance with U.S. GAAP. Net sales and gross margin excluding surcharge
revenue is not a U.S. GAAP financial measure and should not be considered in
isolation of, or as a substitute for, net sales and gross margin calculated in
accordance with U.S. GAAP.

Adjusted Operating Margin Excluding Surcharge Revenue and Special Items



This report includes discussions of operating margin as adjusted to exclude the
impact of raw material surcharge revenue and special items which represent
financial measures that have not been determined in accordance with U.S. GAAP.
We present and discuss this financial measure because management believes
removing the impact of raw material surcharge from net sales provides a more
consistent and meaningful basis for comparing results of operations from period
to period for the reasons discussed earlier in this report. In addition,
management believes that excluding special items from operating margin is
helpful in analyzing our operating performance, as these items are not
indicative of ongoing operating performance. Management uses its results
excluding these amounts to evaluate its operating performance and to discuss its
business with investment institutions, our board of directors and others. See
our earlier discussion of operating income (loss) for a reconciliation of
operating income (loss) and operating margin excluding surcharge revenue and
special items to operating income (loss) and operating margin determined in
accordance with U.S. GAAP. Operating margin excluding surcharge revenue and
special items is not a U.S. GAAP financial measure and should not be considered
in isolation of, or as a substitute for, operating margin calculated in
accordance with U.S. GAAP.

                                       36
--------------------------------------------------------------------------------
  Table of Contents
Adjusted Loss Per Share

The following provides a reconciliation of adjusted loss per share, to its most directly comparable U.S. GAAP financial measures:



($ in millions, except per share                Loss Before           Income Tax                                 Loss Per
amounts)                                       Income Taxes             Benefit             Net Loss          Diluted Share*
Three Months Ended September 30, 2022,
as reported                                   $       (7.8)         $        0.9          $     (6.9)         $      (0.14)
Special item:

None reported                                            -                     -                   -                     -

Three Months Ended September 30, 2022,
as adjusted                                   $       (7.8)         $        0.9          $     (6.9)         $      (0.14)

* Impact per diluted share calculated using weighted average common shares outstanding of 48.7 million for the three months ended September 30, 2022.



                                                  Loss Before           Income Tax                                Loss Per
($ in millions, except per share amounts)        Income Taxes            Benefit             Net Loss          Diluted Share*
Three Months Ended September 30, 2021, as
reported                                        $      (25.2)         $      10.4          $    (14.8)         $      (0.31)
Special item:

COVID-19 costs                                           1.6                 (0.7)                0.9                  0.03

Three Months Ended September 30, 2021, as
adjusted                                        $      (23.6)         $       9.7          $    (13.9)         $      (0.28)

* Impact per diluted share calculated using weighted average common shares outstanding of 48.5 million for the three months ended September 30, 2021.



Management believes that the presentation of loss per share adjusted to exclude
special items is helpful in analyzing the operating performance of the Company,
as these items are not indicative of ongoing operating performance. Our
definitions and calculations of these items may not necessarily be the same as
those used by other companies. Management uses its results excluding these
amounts to evaluate its operating performance and to discuss its business with
investment institutions, our board of directors and others. Adjusted loss per
share is not a U.S. GAAP financial measure and should not be considered in
isolation of, or as a substitute for, loss per share calculated in accordance
with U.S. GAAP.

Free Cash Flow

The following provides a reconciliation of free cash flow, as used in this report, to its most directly comparable U.S. GAAP financial measures:



                                                                Three Months Ended
                                                                  September 30,
($ in millions)                                                 2022           2021
Net cash used for operating activities                      $     (78.0)     $ (47.0)
Purchases of property, plant, equipment and software              (13.5)       (14.4)

Dividends paid                                                     (9.8)        (9.8)

Free cash flow                                              $    (101.3)     $ (71.2)



Management believes that the presentation of free cash flow provides useful
information to investors regarding our financial condition because it is a
measure of cash generated which management evaluates for alternative uses. It is
management's current intention to use excess cash to fund investments in capital
equipment, acquisition opportunities and consistent dividend payments. Free cash
flow is not a U.S. GAAP financial measure and should not be considered in
isolation of, or as a substitute for, cash flows calculated in accordance with
U.S. GAAP.

                                       37
--------------------------------------------------------------------------------

  Table of Contents
Contingencies

Environmental

We are subject to various federal, state, local and international environmental
laws and regulations relating to pollution, protection of public health and the
environment, natural resource damages and occupational safety and health.
Although compliance with these laws and regulations may affect the costs of our
operations, compliance costs to date have not been material. We have
environmental remediation liabilities at some of our owned operating facilities
and have been designated as a PRP with respect to certain third party Superfund
waste-disposal sites and other third party-owned sites. We accrue amounts for
environmental remediation costs that represent our best estimate of the probable
and reasonably estimable future costs related to environmental remediation.
During the three months ended September 30, 2022, the Company increased the
liability for a Company-owned former operating site by $0.1 million. The
liabilities recorded for environmental remediation costs at Superfund sites,
other third party-owned sites and Carpenter-owned current or former operating
facilities remaining at September 30, 2022 and June 30, 2022 were $18.4 million
and $18.3 million, respectively. Additionally, we have been notified that we may
be a PRP with respect to other Superfund sites as to which no proceedings have
been instituted against us. Neither the exact amount of remediation costs nor
the final method of their allocation among all designated PRPs at these
Superfund sites have been determined. Accordingly, at this time, we cannot
reasonably estimate expected costs for such matters. The liability for future
environmental remediation costs that can be reasonably estimated is evaluated on
a quarterly basis.

Estimates of the amount and timing of future costs of environmental remediation
requirements are inherently imprecise because of the continuing evolution of
environmental laws and regulatory requirements, the availability and application
of technology, the identification of currently unknown remediation sites and the
allocation of costs among the PRPs. Based upon information currently available,
such future costs are not expected to have a material effect on our financial
position, results of operations or cash flows over the long-term. However, such
costs could be material to our financial position, results of operations or cash
flows in a particular future quarter or year.

Other



We are defending various routine claims and legal actions that are incidental to
our business, and that are common to our operations, including those pertaining
to product claims, commercial disputes, patent infringement, employment actions,
employee benefits, compliance with domestic and foreign laws, personal injury
claims and tax issues. Like many other manufacturing companies in recent years
we, from time to time, have been named as a defendant in lawsuits alleging
personal injury as a result of exposure to chemicals and substances in the
workplace such as asbestos. We provide for costs relating to these matters when
a loss is probable and the amount of the loss is reasonably estimable. The
effect of the outcome of these matters on our future results of operations and
liquidity cannot be predicted because any such effect depends on future results
of operations and the amount and timing (both as to recording future charges to
operations and cash expenditures) of the resolution of such matters. While it is
not feasible to determine the outcome of these matters, we believe that the
total liability from these matters will not have a material effect on our
financial position, results of operations or cash flows over the long-term.
However, there can be no assurance that an increase in the scope of pending
matters or that any future lawsuits, claims, proceedings or investigations will
not be material to our financial position, results of operations or cash flows
in a particular future quarter or year.

Critical Accounting Policies and Estimates



A summary of other significant accounting policies is discussed in our 2022
Form 10-K Item 7. "Management's Discussion and Analysis of Financial Condition
and Results of Operations", and in Note 1, Summary of Significant Accounting
Policies, of the Notes to our consolidated financial statements included in
Part II, Item 8 thereto.

                                       38
--------------------------------------------------------------------------------
  Table of Contents
Long-Lived Assets

Long-lived assets are reviewed for impairment and written down to fair value
whenever events or changes in circumstances indicate that the carrying value may
not be recoverable through estimated future undiscounted cash flows. The amount
of the impairment loss is the excess of the carrying amount of the impaired
assets over the fair value of the assets based upon estimated future discounted
cash flows. We evaluate long-lived assets for impairment by individual business
unit. Changes in estimated cash flows could have a significant impact on whether
or not an asset is impaired and the amount of the impairment.

Goodwill

Goodwill is not amortized but instead is tested at least annually for impairment
as of June 1, or more frequently if events or circumstances indicate that the
carrying amount of goodwill may be impaired. Potential impairment is identified
by comparing the fair value of a reporting unit to its carrying value. If the
carrying value of the reporting unit exceeds its fair value, any impairment loss
is measured by the difference between the carrying value of the reporting unit
and its fair value, not to exceed the carrying amount of goodwill. The
discounted cash flow analysis for each reporting unit tested requires
significant estimates and assumptions related to cash flow forecasts, discount
rates, terminal values and income tax rates. The cash flow forecasts include
significant judgments and assumptions related to revenue growth rates, which
include perpetual growth rates, gross margin and weighted average cost of
capital. The cash flow forecasts are developed based on assumptions about each
reporting unit's markets, product offerings, pricing, capital expenditure and
working capital requirements as well as cost performance.

The discount rates used in the discounted cash flow are estimated based on a
market participant's perspective of each reporting unit's weighted average cost
of capital. The terminal value, which represents the value attributed to the
reporting unit beyond the forecast period, is estimated using a perpetuity
growth rate assumption. The income tax rates used in the discounted cash flow
analysis represent estimates of the long-term statutory income tax rates for
each reporting unit based on the jurisdictions in which the reporting units
operate.

As of September 30, 2022, we have three reporting units with goodwill recorded.
Goodwill associated with the SAO reporting unit as of September 30, 2022 was
$195.5 million and represents approximately 81 percent of our total goodwill.
The remaining goodwill is associated with the PEP segment, which includes two
reporting units, Dynamet and Latrobe Distribution, with goodwill recorded as of
September 30, 2022 of $31.9 million and $14.0 million, respectively.

Goodwill associated with the SAO reporting unit is tested at the SAO segment
level. The fair value is estimated using a weighting of discounted cash flows
and the use of market multiples valuation techniques. As of June 1, 2022, the
fair value of the SAO reporting unit exceeded the carrying value by
approximately 38.2 percent. The discounted cash flows analysis for the SAO
reporting unit includes assumptions related to our ability to increase volume,
improve mix, expand product offerings and continue to implement opportunities to
reduce costs over the next several years. For purposes of the discounted cash
flow analysis for SAO's fair value, a weighted average cost capital of 9.5
percent and a terminal growth rate assumption of 2.5 percent were used. If the
long-term growth rate for this reporting unit had been hypothetically reduced by
0.5 percent at June 1, 2022, the SAO reporting unit would have a fair value that
exceeded the carrying value by approximately 34.5 percent.

Goodwill associated with the PEP segment is tested at the Dynamet and Latrobe
Distribution reporting unit level. As of June 1, 2022, the fair value of the
Dynamet reporting unit exceeded the carrying value by approximately 54.1
percent. For purposes of the discounted cash flow analysis for Dynamet's fair
value, a weighted average cost capital of 13.0 percent and a terminal growth
rate assumption of 2.5 percent were used. If the long-term growth rate for this
reporting unit had been hypothetically reduced by 0.5 percent at June 1, 2022,
the Dynamet reporting unit would have a fair value that exceeded the carrying
value by approximately 52.0 percent. As of June 1, 2022, the fair value of the
Latrobe Distribution reporting unit exceeded the carrying value by approximately
34.5 percent. For purposes of the discounted cash flow analysis for Latrobe
Distribution's fair value, a weighted average cost capital of 11.0 percent and a
terminal growth rate assumption of 2.5 percent were used. If the long-term
growth rate for this reporting unit had been hypothetically reduced by 0.5
percent at June 1, 2022, the Latrobe Distribution reporting unit would have a
fair value that exceeded the carrying value by approximately 32.1 percent.

                                       39
--------------------------------------------------------------------------------
  Table of Contents
The estimate of fair value requires significant judgment. We based our fair
value estimates on assumptions that we believe to be reasonable but that are
unpredictable and inherently uncertain, including estimates of future growth
rates and operating margins and assumptions about the overall economic climate
and the competitive environment for our business units. There can be no
assurance that our estimates and assumptions made for purposes of our goodwill
and identifiable intangible asset testing as of the time of testing will prove
to be accurate predictions of the future. If our assumptions regarding business
projections, competitive environments or anticipated growth rates are not
correct, we may be required to record goodwill and/or intangible asset
impairment charges in future periods, whether in connection with our next annual
impairment testing or earlier, if an indicator of an impairment is present
before our next annual evaluation. We continuously monitor for events and
circumstances that could negatively impact the key assumptions in determining
fair value of the reporting units.

New Accounting Pronouncements



For information with respect to new accounting pronouncements and the impact of
these pronouncements on our consolidated financial statements, see Note 2 to
Notes to Consolidated Financial Statements included in Item 1.

Forward-Looking Statements



This Quarterly Report on Form 10-Q contains forward-looking statements within
the meaning of the Private Securities Litigation Act of 1995. These
forward-looking statements are subject to risks and uncertainties that could
cause actual results to differ from those projected, anticipated or implied. The
most significant of these uncertainties are described in Carpenter Technology's
filings with the Securities and Exchange Commission, including its report on
Form 10-K for the year ended June 30, 2022, and the exhibits attached to such
filing. They include but are not limited to: (1) the cyclical nature of the
specialty materials business and certain end-use markets, including aerospace,
defense, medical, transportation, energy, industrial and consumer, or other
influences on Carpenter Technology's business such as new competitors, the
consolidation of competitors, customers, and suppliers or the transfer of
manufacturing capacity from the United States to foreign countries; (2) the
ability of Carpenter Technology to achieve cash generation, growth, earnings,
profitability, operating income, cost savings and reductions, qualifications,
productivity improvements or process changes; (3) the ability to recoup
increases in the cost of energy, raw materials, freight or other factors; (4)
domestic and foreign excess manufacturing capacity for certain metals; (5)
fluctuations in currency exchange rates; (6) the effect of government trade
actions; (7) the valuation of the assets and liabilities in Carpenter
Technology's pension trusts and the accounting for pension plans; (8) possible
labor disputes or work stoppages; (9) the potential that our customers may
substitute alternate materials or adopt different manufacturing practices that
replace or limit the suitability of our products; (10) the ability to
successfully acquire and integrate acquisitions; (11) the availability of credit
facilities to Carpenter Technology, its customers or other members of the supply
chain; (12) the ability to obtain energy or raw materials, especially from
suppliers located in countries that may be subject to unstable political or
economic conditions; (13) Carpenter Technology's manufacturing processes are
dependent upon highly specialized equipment located primarily in facilities in
Reading and Latrobe, Pennsylvania and Athens, Alabama for which there may be
limited alternatives if there are significant equipment failures or a
catastrophic event; (14) the ability to hire and retain key personnel, including
members of the executive management team, management, metallurgists and other
skilled personnel; (15) fluctuations in oil and gas prices and production; (16)
uncertainty regarding the return to service of the Boeing 737 MAX aircraft and
the related supply chain disruption; (17) potential impacts of the COVID-19
pandemic on our operations, financial results and financial position; (18) our
efforts and efforts by governmental authorities to mitigate the COVID-19
pandemic, such as travel bans, shelter in place orders and business closures,
and the related impact on resource allocations and manufacturing and supply
chains; (19) our ability to execute our business continuity, operational, budget
and fiscal plans in light of the COVID-19 pandemic; and (20) our ability to
successfully carry out restructuring and business exit activities on the
expected terms and timelines. Any of these factors could have an adverse and/or
fluctuating effect on Carpenter Technology's results of operations. The
forward-looking statements in this document are intended to be subject to the
safe harbor protection provided by Section 27A of the Securities Act of 1933, as
amended (the "Securities Act"), and Section 21E of the Securities Exchange Act
of 1934, as amended. We caution you not to place undue reliance on
forward-looking statements, which speak only as of the date of this Form 10-Q or
as of the dates otherwise indicated in such forward-looking statements.
Carpenter Technology undertakes no obligation to update or revise any
forward-looking statements.
                                       40

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses